Citius Pharmaceuticals, Inc. Income (Loss) from Continuing Operations, Per Diluted Share
Citius Pharmaceuticals, Inc. (CTXR) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.06 per share for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2024-08-12
- Citius Pharmaceuticals, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2024-06-30 was -$0.06.
- Citius Pharmaceuticals, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2024-03-31 was -$0.05.
- Citius Pharmaceuticals, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2023-12-31 was -$0.06.
- Citius Pharmaceuticals, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2023-06-30 was -$0.06.
- Citius Pharmaceuticals, Inc. income (loss) from continuing operations, per diluted share for fiscal 2023 was -$0.22.
- Citius Pharmaceuticals, Inc. income (loss) from continuing operations, per diluted share for fiscal 2022 was -$0.23.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$0.06 10-Q · filed 2024-08-12 | -$0.17 10-Q · filed 2024-08-12 | ||
| 2024-03-31 | -$0.05 10-Q · filed 2024-05-14 | -$0.11 10-Q · filed 2024-05-14 | ||
| 2023-12-31 | -$0.06 10-Q · filed 2024-02-14 | |||
| 2023-09-30 | -$0.22 10-K · filed 2023-12-29 | |||
| 2023-06-30 | -$0.06 10-Q · filed 2024-08-12 | -$0.15 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | -$0.07 10-Q · filed 2024-05-14 | -$0.10 10-Q · filed 2024-05-14 | ||
| 2022-12-31 | -$0.02 10-Q · filed 2024-02-14 | |||
| 2022-09-30 | -$0.23 10-K · filed 2023-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |